- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Applicare launches RadWorks WebViewer
Applicare launches RadWorks WebViewerDutch PACS firm Applicare Medical Imaging has developed a beta version of RadWorks WebViewer, a Web-based image viewing product designed to run on Microsoft Explorer 4.0 or higher. RadWorks WebViewer employs
Applicare launches RadWorks WebViewer
Dutch PACS firm Applicare Medical Imaging has developed a beta version of RadWorks WebViewer, a Web-based image viewing product designed to run on Microsoft Explorer 4.0 or higher. RadWorks WebViewer employs the same user interface as Applicare's Windows NT-based Radworks PACS software and utilizes dynamic hypertext markup language (HTML). Images and reports can be retrieved from the server, which can access data from remote DICOM devices. The offering will include a licensed server and free downloadable client applications, which will install automatically,
according to the company. RadWorks WebViewer will be beta tested at several U.S. sites, including the University of Utah and the
USS Comfort
, a U.S. Navy ship.
- Search again
- Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
